Leica Microsystems has introduced an enhanced version of its digital microscope, ARveo 8, for visualization in neurosurgery. The evolving ecosystem of ARveo 8 facilitates operative visualization through the use of 3D view and augmented reality (AR) with fluorescence, according to an official press release.
Leica’s new innovation, GLOW400, based on AR 3D fluorescence technology, allows neurosurgeons to “achieve a new level of clinical value creation” during brain tumor surgery, thanks to clear visualization of anatomical structures and diverse fluorescence information. In vascular surgery, operators can now observe the flow of blood vessels in a three-dimensional fluorescent format using GLOW800 technology.
The advanced visual features offered by ARveo 8 are now also available through a new, versatile visualization kit called MyVeo. Leica claims that this kit provides surgeons and assistants with freedom of movement, without the need to maintain positions in front of eyepieces or external monitors, thus providing greater ergonomic comfort and a new level of surgical work efficiency.
“The continuously evolving ARveo 8 is once again pushing the boundaries in the field of neurosurgery,” said Walid Beylouni, Vice President of the Medical Division at Leica. “It opens up new possibilities for continuous access to clinical applications and digital capabilities. Surgeons will see more information, leading to the creation of clinical value during critical procedures. The result is more confident real-time surgical decisions.”
The innovative GLOW400 AR fluorescence technology in brain tumor surgeries, which is awaiting approval by the Food and Drug Administration (FDA) in the United States, takes the visualization of suspected Class III and IV tumors to a “higher level,” according to the company’s latest press release. Anatomical details are made more vivid thanks to GLOW400 Anatomy View, a multi-spectral imaging technology. Even details such as blood vessels and bleeding, which were previously concealed under blue light, are now visible, according to Leica.
Additionally, surgeons can observe a wider range of fluorescence intensities through GLOW400 Highlighted Fluorescence View. During tumor removal, they can repeatedly check for traces of visible fluorescence, especially signals with lower intensity, which are marked on the tumor. Real-time digital fluorescence images are displayed in high resolution in 2D or 3D format on a large 55-inch monitor available in the enhanced ARveo 8.
“With the MyVeo visualization kit, surgeons can now experience the future of digital surgery,” emphasizes Leica.
FAQ Section based on the main topics and information presented in the article:
1. What is the ARveo 8 digital microscope?
The ARveo 8 digital microscope is an enhanced version of a microscope introduced by Leica Microsystems for visualization in neurosurgery.
2. How does ARveo 8 facilitate operative visualization?
ARveo 8 facilitates operative visualization through the use of 3D view and augmented reality (AR) with fluorescence.
3. What is GLOW400?
GLOW400 is a new technology developed by Leica, based on AR 3D fluorescence technology, that enables neurosurgeons to have clear visualization of anatomical structures and diverse fluorescence information during brain tumor surgery.
4. What advanced visual features are offered by ARveo 8?
ARveo 8 offers advanced visual features through the new versatile visualization kit, MyVeo. This kit provides surgeons and assistants with freedom of movement, without the need to maintain positions in front of eyepieces or external monitors, thus providing greater ergonomic comfort and a new level of surgical work efficiency.
5. How does ARveo 8 contribute to the creation of clinical value?
ARveo 8 allows surgeons to see more information, leading to the creation of clinical value during critical procedures. This enables more confident real-time surgical decisions.
6. How does the GLOW400 technology enhance brain tumor visualization?
GLOW400, a future AR fluorescence technology, takes the visualization of suspected Class III and IV brain tumors to a “higher level”. Anatomical details are made more vivid, and even details such as blood vessels and bleeding, which were previously concealed under blue light, are now visible.
7. What are the additional capabilities of GLOW400?
GLOW400 allows surgeons to observe a wider range of fluorescence intensities and repeatedly check for traces of fluorescence during tumor removal. Real-time digital fluorescence images are displayed in high resolution on a large 55-inch monitor.
Sample anchor text links to the main domain:
– Leica Microsystems
– FDA
The source of the article is from the blog revistatenerife.com